Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Dividend Reinstated and Contract Win

13 Aug 2020 11:00

RNS Number : 0651W
Croma Security Solutions Group PLC
13 August 2020
 

 

13 August 2020

CROMA SECURITY SOLUTIONS GROUP PLC

("CSSG" or the "Group")

Reinstatement of Dividend and Contract Win

Croma Security Solutions Group Plc, the total security services provider, is pleased to announce the reinstatement of the Company's interim dividend. On 19 March 2020, as a precaution against the potential impact of Covid-19, the Company cancelled the interim dividend announced alongside the Interim Results. Having now completed the financial year to 30 June 2020, it is clear the impact of Covid-19 on Group has been light.

As a consequence, the Company intends to pay an interim dividend of 0.75p per share on 4 September 2020 to shareholders with an ex-dividend date of 20 August 2020 and an associated record date of 21 August 2020.

The Company is also pleased to confirm that post-year end, Croma Vigilant has won a guarding contract from Savills to manage the security for the Edinburgh St James centre. A £1 billion redevelopment, the centre is a major scheme in the heart of Edinburgh and is due to open in Spring 2021. The guarding contract is for 3 years, worth £1.3 million annually and commences from 2 April 2021.

The centre includes retail, commercial and residential buildings and under the new contract, Croma Vigilant will provide a range of its premium guarding services including PROception. Led by ex-policewoman Ruth McGowan, PROception was launched in 2019 and brings the amalgamation of 3 key disciplines: reception, concierge and security, to create the modern front of house professional.

Chairman, Sebastian Morley, said, "At the outbreak of the Covid-19 pandemic in March we took the decision to cancel the dividend until we gained greater visibility on the impact it might have. Pleasingly, the impact has been slight, due in part to the organisation and flexibility of our teams which maintained all services at full strength. Having now completed the financial year, we expect we will deliver a good financial performance and with no borrowings and record levels of cash we are comfortable in re-instating the interim dividend.

The Edinburgh St James centre security contract was a highly competitive tender and as a team we are delighted to have been chosen and believe our premium security services coupled with the range of additional capabilities we are able to provide were instrumental in securing this prestigious contract."

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For further information contact:

Croma Security Solutions Group plc

Sebastian Morley, Chairman

 

 

Tel: +44 (0)7768 006 909

WH Ireland Limited (NOMAD and Broker)

Mike Coe / Chris Savidge

 

Tel: +44 (0)207 220 1666

Novella Communications

Tim Robertson / Fergus Young

Tel: +44 (0)203 151 7008

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVKXLBFBVLZBBZ
Date   Source Headline
16th Mar 20267:00 amRNSAcquisition
16th Mar 20267:00 amRNSAcquisition
26th Feb 20267:00 amRNSHalf-year Financial Report
23rd Feb 20264:58 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSNotice of Results
15th Jan 20268:32 amRNSDirector Dealing
5th Jan 20267:00 amRNSAcquisition
1st Dec 202511:30 amRNSResult of AGM
25th Nov 20257:00 amRNSNotice of AGM
3rd Nov 20257:00 amRNSFinal Results
30th Oct 20257:00 amRNSNotice of Results and Investor Presentation
23rd Oct 20257:00 amRNSDirectorate Change
5th Sep 20251:59 pmRNSBoard Change
2nd Sep 20253:29 pmRNSBoard Change
16th Jul 202511:19 amRNSHolding(s) in Company
9th Jul 20257:00 amRNSTrading Statement
8th May 20253:55 pmRNSDirector/PCA Dealings
25th Apr 20256:10 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAcquisition
6th Mar 20257:00 amRNSGrant of Options
24th Feb 20257:00 amRNSHalf-year Report
19th Feb 20257:00 amRNSNotice of Results and Investor Presentations
3rd Feb 20257:00 amRNSAcquisition
20th Jan 20257:00 amRNSTrading Statement
4th Dec 20249:26 amRNSResult of AGM
4th Dec 20247:00 amRNSAGM Statement
28th Nov 20247:00 amRNSNotice of AGM
5th Nov 202411:10 amRNSDirector Dealing
5th Nov 20247:00 amRNSNotice of Investor Presentation
4th Nov 20247:00 amRNSFinal Results
29th Oct 20242:38 pmRNSDirector/PCA Dealings
14th Aug 20247:00 amRNSHolding(s) in Company
22nd Jul 20247:00 amRNSTrading Statement
15th Jul 20247:00 amRNSChange of Adviser
8th Jul 20247:00 amRNSReceipt of Deferred Consideration
3rd Apr 20247:00 amRNSNHS Contract Win
21st Feb 20247:00 amRNSHalf-year Report
29th Jan 20247:00 amRNSTrading Statement
8th Jan 20247:00 amRNSAcquisition
1st Dec 202310:24 amRNSResult of AGM
16th Nov 20237:00 amRNSNotice of AGM
13th Nov 202312:54 pmRNSDirector Dealing
13th Nov 20237:00 amRNSGrant of Options
8th Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFinal Results
26th Oct 20232:42 pmRNSTransaction in own shares and total voting rights
26th Oct 20237:00 amRNSTransaction in own shares and total voting rights
8th Aug 202310:17 amRNSHolding(s) in Company
7th Aug 202311:10 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.